Xadago 50 mg/1
safinamide mesylate · TABLET, FILM COATED · MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
Xadago is a tablet, film coated containing safinamide mesylate at 50 mg/1, taken oral. Manufactured by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Xadago
- Generic Name
- safinamide mesylate
- NDC Code (Product)
27505-110- Manufacturer
- MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA207145
- Marketing Start
- 05/08/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Xadago used for?
Xadago contains safinamide mesylate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Xadago a controlled substance?
Xadago is not classified as a controlled substance by the DEA.
What is the generic name for Xadago?
The generic name for Xadago is safinamide mesylate. There are no other listed brand versions of safinamide mesylate.
What is the NDC code for Xadago 50 mg/1?
The NDC (National Drug Code) for Xadago 50 mg/1 is 27505-110, listed by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc..
Other Xadago Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)